FDA acquires GEA ConsiGma 1 unit for their CDER/OPQ Continuous Lab
2018-02-03
The FDA has purchased a GEA ConsiGma(TM) 1 OSD development unit, which is housed in the CDER/OPQ (Office of Pharmaceutical Quality). The GEA ConsiGma(TM) 1 will be an important asset for continuous manufacturing research within the OPQ Office of Testing and Research and Emerging Technologies Team.
